Haemonetics Corporation (HAE) — Stock Score Summary

Haemonetics Corporation (HAE) has a MoatMap StockRank of 83/100 based on Quality (66/100), Value (45/100), and Momentum (54/100) factor scores. The current signal is STRONG BUY. Haemonetics is a solid medical technology business, but it lacks direct alignment with our high-conviction 18-month macro themes.

Haemonetics Corporation is a global healthcare company providing innovative blood management solutions, including blood and plasma collection, processing, and patient blood management devices. It is a leader in blood management technology, offering proprietary automated devices and consumables that optimize the collection and processing of blood components. Its specialized solutions address critical needs in healthcare, creating strong customer lock-in and a significant competitive moat.

Key Financial Metrics

Price$69.85
Market Cap$3.0B
P/E (TTM)34.07
P/E (Forward)12.11
Price/Book3.97
Return on Equity12.0%
Return on Invested Capital11.8%
Debt/Equity160.08
Gross Margin59.4%
Operating Margin13.9%
Revenue Growth4.8%
Free Cash Flow$298M

Haemonetics Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Haemonetics Corporation’s (HAE) StockRank?
MoatMap’s StockRank for Haemonetics Corporation (HAE) is 83/100, with a Strong Buy signal. It is a composite of Quality (66), Value (45), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Haemonetics Corporation have an economic moat?
Haemonetics Corporation (HAE) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Haemonetics Corporation a buy, hold, or sell?
MoatMap’s current signal for Haemonetics Corporation (HAE) is Strong Buy, based on a StockRank of 83/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Haemonetics Corporation in?
Haemonetics Corporation (HAE) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksHAE deep dive reportAI ChampionsHow we score stocksSense-check another stock